WO2002044201A3 - Haplotypes du gene sah - Google Patents

Haplotypes du gene sah Download PDF

Info

Publication number
WO2002044201A3
WO2002044201A3 PCT/US2001/047011 US0147011W WO0244201A3 WO 2002044201 A3 WO2002044201 A3 WO 2002044201A3 US 0147011 W US0147011 W US 0147011W WO 0244201 A3 WO0244201 A3 WO 0244201A3
Authority
WO
WIPO (PCT)
Prior art keywords
haplotypes
sah
gene
disclosed
sah gene
Prior art date
Application number
PCT/US2001/047011
Other languages
English (en)
Other versions
WO2002044201A2 (fr
Inventor
Karyn M Bieglecki
Anne Chew
David P Russo
Original Assignee
Genaissance Pharmaceuticals
Karyn M Bieglecki
Anne Chew
David P Russo
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Genaissance Pharmaceuticals, Karyn M Bieglecki, Anne Chew, David P Russo filed Critical Genaissance Pharmaceuticals
Priority to AU2002230657A priority Critical patent/AU2002230657A1/en
Publication of WO2002044201A2 publication Critical patent/WO2002044201A2/fr
Publication of WO2002044201A3 publication Critical patent/WO2002044201A3/fr

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00Oligonucleotides characterized by their use
    • C12Q2600/156Polymorphic or mutational markers
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00Oligonucleotides characterized by their use
    • C12Q2600/172Haplotypes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Analytical Chemistry (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Pathology (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

L'invention concerne de nouvelles variantes génétiques du gène homologue de SA (associé à l'hypertension murin) (SAH) ; divers génotypes, haplotypes, et paires d'haplotypes du gène SAH qui existent dans la population générale des Etats-Unis ; des compositions et des procédés d'haplotypage et/ou de génotypage du gène SAH chez un sujet ; des polynucléotides définis par les haplotypes décrits.
PCT/US2001/047011 2000-12-01 2001-12-03 Haplotypes du gene sah WO2002044201A2 (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU2002230657A AU2002230657A1 (en) 2000-12-01 2001-12-03 Haplotypes of the sah gene

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US25044100P 2000-12-01 2000-12-01
US60/250,441 2000-12-01

Publications (2)

Publication Number Publication Date
WO2002044201A2 WO2002044201A2 (fr) 2002-06-06
WO2002044201A3 true WO2002044201A3 (fr) 2003-07-17

Family

ID=22947759

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2001/047011 WO2002044201A2 (fr) 2000-12-01 2001-12-03 Haplotypes du gene sah

Country Status (2)

Country Link
AU (1) AU2002230657A1 (fr)
WO (1) WO2002044201A2 (fr)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2854639A1 (fr) * 2003-05-07 2004-11-12 Galderma Res & Dev Genes du psoriasis.

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
DATABASE GENBANK [online] THE INSTITUTE FOR GENOMIC RESEARCH; 14 July 1998 (1998-07-14), ADAMS M.D.: "Human chromosome 16p13 BAC clone CIT987SK44M2", XP002961902, accession no. NCBI Database accession no. (AC004381) *
LOFTUS ET AL.: "Genome duplication and other features in 12 Mb of DNA sequence from human chromosome 16p and 16q", GENOMICS, vol. 60, 1999, pages 295 - 308, XP002931311 *

Also Published As

Publication number Publication date
WO2002044201A2 (fr) 2002-06-06
AU2002230657A1 (en) 2002-06-11

Similar Documents

Publication Publication Date Title
WO2002026768A3 (fr) Haplotypes du gene por
WO2001079234A3 (fr) Haplotypes du gene apoe
WO2002008425A3 (fr) Haplotypes du gene adrb3
WO2002018414A3 (fr) Haplotypes du gène bf
WO2002044201A3 (fr) Haplotypes du gene sah
WO2002090512A3 (fr) Haplotypes du gene nnmt
WO2002012498A3 (fr) Haplotypes du gene isl1
WO2001087909A3 (fr) Haplotypes du gene aanat
WO2002012562A3 (fr) Haplotypes du gene pla2g1b
WO2002050098A3 (fr) Haplotypes du gene du recepteur de la prolactine (prlr)
WO2002032928A3 (fr) Haplotypes du gene hrh1
WO2002040502A3 (fr) Haplotypes du gene de la lipase hormono-sensible
WO2001090127A3 (fr) Haplotypes du gene de hoxd3
WO2001090120A3 (fr) Haplotypes du gene evx1
WO2002042320A3 (fr) Haplotypes du gene de glutathione reductase
WO2002036610A3 (fr) Haplotypes du gene adora3
WO2002026770A3 (fr) Haplotypes du gene admr
WO2002016399A3 (fr) Haplotypes du gene tacr1
WO2002038586A3 (fr) Haplotypes du gene il6
WO2002090378A3 (fr) Haplotypes du gene de ces2
WO2002030950A3 (fr) Haplotypes du gene fy
WO2001085742A3 (fr) Haplotypes du gene npy1r
WO2001087907A3 (fr) Haplotypes du gene de l'osm
WO2002032924A3 (fr) Haplotypes du gene chrm5
WO2002010190A3 (fr) Haplotypes du gene il12b

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PH PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

122 Ep: pct application non-entry in european phase
NENP Non-entry into the national phase

Ref country code: JP

WWW Wipo information: withdrawn in national office

Country of ref document: JP